Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Location status: Recruiting
NCT Number: NCT05589207
The goal of this observational study is to establish a preoperative imaging diagnostic model which highly consistent with the histopathological examinations, as well as a accurate and systematic pathological grading standard of inferior vena cava (IVC) vascular wall invasion in renal cell carcinoma (RCC) with tumor thrombus invading vascular wall.The main questions it aims to answer are:
* To establish a preoperative imaging diagnostic model which highly consistent with the histopathological examinations. * To determine what impact does different vascular wall layer invasion make on the long-term prognosis in RCC with IVC tumor thrombus; * To determine which layer invasion according to pathological examination make sense to clinical treatment (can significantly affect prognosis); Participants with IVC vascular wall invasion/ non-invasion are divided into experimental group (invaded group) or control group (non-invaded group) respectively according to pathological examinations, in order to establish a prospective cohort with three-year follow-up. The pathological characteristics of local recurrence and poor prognosis are summarized, and postoperative pathological diagnostic criteria of IVC vascular wall invasion and established. The local recurrence and distant recurrence outcomes are compared between experiment group and control group, in order to analyze the long-term influence of vascular wall invasion. Then the preoperative imaging diagnostic evaluation model will be established.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100191, China
Location status: Recruiting
Radical nephrectomy and thrombectomy are essential surgical treatments for renal cell carcinoma (RCC) with inferior vena cava (IVC) tumor thrombus. IVC vascular wall invasion leads to higher recurrence risk and worse long-term prognosis. The diagnosis and treatment of RCC tumor thrombus with IVC vascular wall invaded are affected by prominent difficulties: First, there is a lack of the preoperative diagnostic evaluation system consisting to the postoperative histopathological examinations, which is regarded as the gold standard of vascular wall invasion, therefore hinders the development of the neoadjuvant therapy strategy and surgery plan; Besides, the pathological diagnostic criteria of IVC vascular wall adhesion or invasion is inconsistent among different centers, an accurate and systematic criteria is needed.
This study consecutively includes patients admitted in Peking University Third Hospital between January 2023 to January 2026, who were diagnosed with primary renal cell carcinoma with IVC tumor thrombus with/without vascular wall invasion, and accepted radical nephrectomy and at least one IVC thrombectomy (including IVC incision only, IVC partial resection, IVC diagonal resection, and IVC segmental resection). The patients with IVC vascular wall invasion/ non-invasion are divided into experimental group (invaded group) or control group (non-invaded group) respectively according to pathological examinations, in order to establish a prospective cohort with three-year follow-up. For the invaded group, micro invasion subgroup and tumor thrombus capsule subgroup analysis are conducted. The pathological characteristics of local recurrence and poor prognosis are summarized, and postoperative pathological diagnostic criteria of IVC vascular wall invasion and established. The local recurrence and distant recurrences outcomes are compared between experiment group and control group, in order to analyze the long-term influence of vascular wall invasion. Then the preoperative imaging diagnostic evaluation model were established: re-diagnose patients in two groups according to the established pathological diagnostic criteria, and divide them into truly-invaded group and truly-non-invaded group. Analyzing the preoperative abdominal ultrasound scan, contrast-enhanced ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI), thus explore the imaging characteristics of vascular wall invasion and establish the preoperative diagnostic model. This study aims at establish a preoperative imaging diagnostic model which highly consistent with the histopathological examinations, as well as a accurate and systematic pathological grading standard of IVC vascular wall invasion, therefore contribute to the development of a more accurate and effective preoperative treatment strategy and surgery plan.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inferior vena cava vascular wall is invaded according to pathologic examination on the postoperative tumor thrombus/ vascular wall specimen.
Time frame: From date of randomization until the date of lost follow-up or date of death from any cause, whichever came first, assessed up to 120 months
The duration from the date of diagnosis to death or last follow-up, with no restriction on the cause of death.
Time frame: From the clinical diagnosis until the surgery, an average of 3 weeks
Clinical manifestation related to the renal carcinoma
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
A universal grading system for renal tumor thrombus.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Diameter of the primary tumor.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
TNM stage according to the preoperative imaging.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Inferior vena cava residual blood flow according to ultrasonography.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Inferior vena cava vascular wall continuity according to ultrasonography.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Whether the inferior vena cava is completely occluded according to ultrasonography.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Whether the inferior vena cava enhanced synchronization with tumor thrombus according to ultrasonography.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Whether the tumor thrombus move when breathe according to ultrasonography.
Time frame: The time once the preoperative imaging was assessed, up to 1 weeks.
Maximum inferior vena cava anterior-posterior diameter according to CT/ MRI.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Maximun coronal inferior vena cava diameter according to CT/ MRI.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Maximum inferior vena cava anterior-posterior diameter at the renal vein ostium according to CT/ MRI.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
Maximun coronal inferior vena cava diameter at the renal vein ostium according to CT/ MRI.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
The presence of bland thrombus in inferior vena cava according to CT/ MRI.
Time frame: The time once the preoperative imaging is assessed, up to 1 weeks.
The presence of tumor thrombus growing against the direction of venous return according to CT/ MRI.
Time frame: The time once the surgery finished, an average of 10 days.
Radical nephrectomy and at least one kind of IVC thrombectomy (including IVC incision only, IVC partial resection, IVC diagonal resection, and IVC segmental resection)
Time frame: The time once the surgery finished, an average of 10 days.
Surgery time
Time frame: The time once the surgery finished, an average of 10 days.
Blood loss during surgery
Time frame: The time once the pathological specimen is assessed, up to 1 weeks.
Histological type of the tumor according to pathological examination.
Time frame: The time once the pathological specimen is assessed, up to 1 weeks.
TNM stage according to pathological examination.
Time frame: The time once the pathological specimen is assessed, up to 1 weeks.
The deepest Inferior vane cava vascular wall layer the tumor thrombus invaded.
Time frame: From the end of surgery until discharge, up to 3 weeks.
The comorbidity occurence after surgery.
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months
The duration from the date of diagnosis to death, last follow-up, or cancer recurrence.
Time frame: Through study completion, an average of 3 year.
Location and time that the metastasis occurs.
Contact information is provided by the study sponsor or research team.
Peking University Third Hospital
Other
Preoperative Imaging Diagnostic Evaluation Model Based on Evidence-based Pathological Diagnose Criteria for Renal Cell Carcinoma Tumor Thrombus With Inferior Vena Cava Wall Invasion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07489495
Adenocarcinoma, Carcinoma
Marietta, Georgia, United States
View Trial DetailsNCT05127824
Adenocarcinoma, Carcinoma
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07227415
Adenocarcinoma, Advanced Renal Cell Carcinoma
Phoenix, Arizona, United States
View Trial DetailsNCT04895709
Adenocarcinoma, Adnexal Diseases
Clovis, California, United States
View Trial Details